← Open Payments lookup

JEFFREY CHONG: Open Payments

NPI 1376644542 · VAN NUYS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$570 in 23 payments from 11 companies in 2025. Trend: 2023 $502 · 2024 $639 · 2025 $570

Food & beverage: $570
CompanyPaymentsAmount
Lilly USA, LLC5$142
Phathom Pharmaceuticals, Inc.3$88
ABBVIE INC.4$69
Merck Sharp & Dohme LLC2$53
SANOFI-AVENTIS U.S. LLC2$52
AstraZeneca Pharmaceuticals LP2$49
Otsuka America Pharmaceutical, Inc.1$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
GlaxoSmithKline, LLC.1$24
Boehringer Ingelheim Pharmaceuticals, Inc.1$23

Products named: VOQUEZNA, VRAYLAR, MOUNJARO, GARDASIL 9, TZIELD, JARDIANCE, REXULTI, ZEPBOUND.

Industry payments across CA — which companies pay providers there.